Article content material
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Firm”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) publicizes that it has modified auditors from McGovern Hurley LLP (“McGovern”) to MNP LLP (“MNP”), efficient November 9, 2023. On the request of the Firm, McGovern has resigned as of the efficient date of November 9, 2023. MNP has been appointed because the successor auditor. In accordance with Nationwide Instrument 51‐102 (“NI 51‐102”), the Firm has filed a Change of Auditor Discover on SEDAR along with letters from each McGovern and MNP, with every letter confirming settlement with the statements contained within the discover, as relevant. There have been no reportable occasions (as outlined in NI 51‐102) between McGovern and the Firm.
Article content material
As well as, the Firm introduced at this time that Wen Ye has resigned from its board of administrators, efficient instantly. Administration and the board wish to thank Ms. Ye for her companies and intensive contributions to the Firm and need her nicely in her future endeavours.
Article content material
About Medivolve, Inc.
Medivolve Inc. is a Canadian healthcare expertise firm headquartered in Toronto, Canada. The Firm’s mission is to enhance well being and lives by delivering world-class diagnostic options—beginning with COVID-19—in addition to to allow quicker and higher care to sufferers by way of modern expertise. Medivolve, by way of its subsidiaries, operates retail patient-care areas in California.
For investing inquiries, please contact: David Preiner, CEO, data@medivolve.ca, 702-990-3737.
Share this text in your social community